|
|
Article: ExonHit Therapeutics Announces the Appointment of Its New Chief Financial Officer.
- Article from:
- Business Wire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PARIS -- Regulatory News:
ExonHit Therapeutics (Paris:ALEHT) today announced the appointment of Herve Duchesne de Lamotte as its Chief Financial Officer. Herve Duchesne de Lamotte has over 25 years of international financial experience, including 10 years within the biotechnology industry.
"We are very pleased to welcome Herve Duchesne de Lamotte to the Company. He will provide ExonHit with the benefit of his strong financial experience in the healthcare field and his international skills in strategy and consulting - all of which are significant assets for the pursuit of our corporate objectives", stated Looc Maurel M.D., President of ExonHit ...